Literature DB >> 24649875

Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study.

Firas S Ahmed1, Xian-cheng Jiang, Joseph E Schwartz, Eric A Hoffman, Joseph Yeboah, Steven Shea, Kristin Marie Burkart, R Graham Barr.   

Abstract

CONTEXT: Ceramide causes endothelial apoptosis and emphysema-like changes in animal models.
OBJECTIVES: Test if plasma sphingomyelin, a major precursor of ceramide, would predict longitudinal increase in the percentage of emphysema-like lung on computed tomography (CT).
MATERIALS AND METHODS: 3840 participants had their plasma sphingomyelin measured at baseline examination and their pulmonary emphysema measured on cardiac CT scans at baseline and on follow-up visits. Mixed effects models were used to adjust for potential confounders.
RESULTS: One standard deviation increase in sphingomyelin predicted a 0.12% per year (95% CI: 0.02-0.22; p = 0.019) greater increase of percent emphysema. DISCUSSION AND
CONCLUSION: Higher plasma levels of sphingomyelin predicted greater annual increase in quantitatively measured percent emphysema.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24649875      PMCID: PMC4088962          DOI: 10.3109/1354750X.2014.896414

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  35 in total

Review 1.  The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

2.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

3.  Emphysema scores predict death from COPD and lung cancer.

Authors:  Javier J Zulueta; Juan P Wisnivesky; Claudia I Henschke; Rowena Yip; Ali O Farooqi; Dorothy I McCauley; Mildred Chen; Daniel M Libby; James P Smith; Mark W Pasmantier; David F Yankelevitz
Journal:  Chest       Date:  2011-10-20       Impact factor: 9.410

4.  Relation of smoking and age to emphysema. Whole-lung section study.

Authors:  O Auerbach; E C Hammond; L Garfinkel; C Benante
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Measurement of lung expansion with computed tomography and comparison with quantitative histology.

Authors:  H O Coxson; J R Mayo; H Behzad; B J Moore; L M Verburgt; C A Staples; P D Paré; J C Hogg
Journal:  J Appl Physiol (1985)       Date:  1995-11

Review 7.  Sphingomyelin-degrading pathways in human cells role in cell signalling.

Authors:  T Levade; N Andrieu-Abadie; B Ségui; N Augé; M Chatelut; J P Jaffrézou; R Salvayre
Journal:  Chem Phys Lipids       Date:  1999-11       Impact factor: 3.329

8.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

Authors:  B M Psaty; M Lee; P J Savage; G H Rutan; P S German; M Lyles
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom.

Authors:  Joan B Soriano; Kourtney J Davis; Bobbie Coleman; George Visick; David Mannino; Neil B Pride
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  12 in total

1.  Bioactive lipids in emphysema. Decoding fat to reveal COPD phenotypes.

Authors:  Mehdi Mirzaie; Farrah Kheradmand
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

2.  Pre-analytic Considerations for Mass Spectrometry-Based Untargeted Metabolomics Data.

Authors:  Dominik Reinhold; Harrison Pielke-Lombardo; Sean Jacobson; Debashis Ghosh; Katerina Kechris
Journal:  Methods Mol Biol       Date:  2019

3.  Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.

Authors:  Jonathan Fallica; Lidenys Varela; Laura Johnston; Bo Kim; Leonid Serebreni; Lan Wang; Mahendra Damarla; Todd M Kolb; Paul M Hassoun; Rachel Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

4.  Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA Lung Study.

Authors:  Carrie P Aaron; Joseph E Schwartz; Suzette J Bielinski; Eric A Hoffman; John H M Austin; Elizabeth C Oelsner; Kathleen M Donohue; Ravi Kalhan; Cecilia Berardi; Joel D Kaufman; David R Jacobs; Russell P Tracy; R Graham Barr
Journal:  Respir Med       Date:  2014-10-22       Impact factor: 3.415

5.  Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.

Authors:  Russell P Bowler; Sean Jacobson; Charmion Cruickshank; Grant J Hughes; Charlotte Siska; Daniel S Ory; Irina Petrache; Jean E Schaffer; Nichole Reisdorph; Katerina Kechris
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

6.  Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice.

Authors:  Giovanna De Cunto; Vincenzo Brancaleone; Maria Antonietta Riemma; Ida Cerqua; Valentina Vellecco; Giuseppe Spaziano; Eleonora Cavarra; Barbara Bartalesi; Bruno D'Agostino; Giuseppe Lungarella; Giuseppe Cirino; Monica Lucattelli; Fiorentina Roviezzo
Journal:  Br J Pharmacol       Date:  2019-11-06       Impact factor: 8.739

7.  A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.

Authors:  Carrie P Aaron; Joseph E Schwartz; Eric A Hoffman; Elsa Angelini; John H M Austin; Mary Cushman; David R Jacobs; Joel D Kaufman; Andrew Laine; Lewis J Smith; Jie Yang; Karol E Watson; Russell P Tracy; R Graham Barr
Journal:  Chest       Date:  2017-12-12       Impact factor: 9.410

8.  Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.

Authors:  Elizabeth C Oelsner; Pallavi P Balte; Morgan E Grams; Patricia A Cassano; David R Jacobs; R Graham Barr; Kristin M Burkart; Ravi Kalhan; Richard Kronmal; Laura R Loehr; George T O'Connor; Joseph E Schwartz; Michael Shlipak; Russell P Tracy; Michael Y Tsai; Wendy White; Sachin Yende
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 30.528

9.  Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells.

Authors:  Yusuke Nakamura; Yasuo Shimizu; Yasuhiro Horibata; Rinna Tei; Ryosuke Koike; Meitetsu Masawa; Taiji Watanabe; Taichi Shiobara; Ryo Arai; Kazuyuki Chibana; Akihiro Takemasa; Hiroyuki Sugimoto; Yoshiki Ishii
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

10.  Serum Acylglycerols Inversely Associate with Muscle Oxidative Capacity in Severe COPD.

Authors:  Rongsong Li; Alessandra Adami; Chih-Chiang Chang; Chi-Hong Tseng; Tzung K Hsiai; Harry B Rossiter
Journal:  Med Sci Sports Exerc       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.